Edition:
United Kingdom

People: Infant Bacterial Therapeutics AB (IBTb.ST)

IBTb.ST on Stockholm Stock Exchange

215.00SEK
13 Sep 2019
Change (% chg)

-6.00kr (-2.71%)
Prev Close
221.00kr
Open
218.00kr
Day's High
221.50kr
Day's Low
203.00kr
Volume
27,027
Avg. Vol
13,215
52-wk High
274.50kr
52-wk Low
115.00kr

Rothschild, Peter 

Mr. Peter Rothschild serves as Chairman of the Board at Infant Bacterial Therapeutics AB. Peter Rothschild is Group President and founder of BioGaia together with Jan Annwall. Peter is an experienced entrepreneur and successful businessman. He guided BioGaia’s establishment and successful development as Managing Director of BioGaia for 19 years. Peter is also Chairman of the board of directors of several companies including TwoPac AB and MetaboGen AB. He holds Master of Business Administration degree.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --